Abiopharma

News list

Director DONALD ARNOLD W 🟡 adjusted position in 0 shares (1 derivative) of Salesforce, Inc. (CRM) Transaction Date: Aug 22, 2026 | Filing ID: 000164

Full text

News bot Aug. 24, 2026, 11:52 p.m.
🔍 DONALD ARNOLD W (Director)

Company: Salesforce, Inc. (CRM)

Report Date: 2026-08-22
Transaction Summary:
- Total transactions: 3
- Derivative instruments: 1
- Holdings reported: 1
- Total shares acquired: 441
- Total shares sold: 441
- Total shares held: 161
Detailed Transactions and Holdings:
- Acquired 441 shares of Common Stock (Direct)
  Date: 2026-08-22 | Code: M | equity_swap_involved: 0 | shares_owned_after: 5,856.00 | transaction_form_type: 4
- Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-22 | Code: H | shares_owned_after: 161.00
- Sold 441 shares of Restricted Stock Units (Derivative)
  Date: 2026-08-22 | Code: M | Expires: 2026-11-22 | Exercise: 2026-02-22 | equity_swap_involved: 0 | shares_owned_after: 441.00 | transaction_form_type: 4 | Footnotes: F1, F2
Footnotes:
- F1: Restricted Stock Units convert to shares of common stock on a one-for-one basis.
- F2: These restricted stock units vest as to 25% of the original grant on each of February 22, 2026, May 22, 2026, August 22, 2026, and November 22, 2026.